Prior notification of a concentration (Case M.10014 — LGP/Centerbridge/Community Psychiatry) Candidate case for simplified procedure (Text with EEA relevance) 2020/C 403/08
Date: 2020-11-26
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, investment company, medical centre, merger control, psychiatry, service








C_2020403EN.01001401.xml










26.11.2020   


EN


Official Journal of the European Union


C 403/14






Prior notification of a concentration
(Case M.10014 — LGP/Centerbridge/Community Psychiatry)
Candidate case for simplified procedure
(Text with EEA relevance)
(2020/C 403/08)

1.   
On 19 November 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Leonard Green & Partners (‘LGP’, United States),










—


Centerbridge Partners, L.P. (‘Centerbridge’, United States),










—


Community Psychiatry Management, LLC (‘Community Psychiatry’, United States), currently controlled by Centerbridge.




LGP and Centerbridge acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Community Psychiatry.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


for LGP: private equity investment firm focused on investing in companies providing services, including consumer, business, and healthcare services, as well as retail, distribution, and industrials, at global level.










—


for Centerbridge: private investment management firm active in private equity, credit, and real estate, at global level.










—


for Community Psychiatry: owns and operates a chain of outpatient clinics in California (United States), providing psychiatric and therapeutic services for patients with mild-to-moderate mental and behavioural disorders.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10014 — LGP/Centerbridge/Community Psychiatry
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.